• Contact Us

    Contact Us Have a question about LUTATHERA®? Contact one of our team members to find out more.

  • NETTER-1: A Pivotal Trial of LUTATHERA®

    NETTER-1: A Pivotal Trial of LUTATHERA® (lutetium [177Lu] oxodotreotide) Read through this slide deck for an overview of the pivotal, randomised controlled NETTER-1 trial. 

  • Quality of Life with LUTATHERA

    Quality of Life with LUTATHERA Learn more about the impact of LUTATHERA® on patients’ quality of life in the NETTER-1 trial.

  • LUTATHERA®: Power Against Progression

    LUTATHERA: Power Against Progression This brochure for a succinct summary of the effectiveness and manageable safety profile of LUTATHERA® in the management of GEP-NETs.

  • PRRT Masterclass Videos

      PRRT Masterclass Videos 2020   Browse our catalogue of videos and watch experts in the field of NETs discuss their clinical insights on the evidence for the diagnosis, management and treatment of NETs, with a focus on PRRT.

  • Patient selection and challenges in PRRT 

    Patient selection and challenges in PRRT  Dr Shaunak Navalkissoor speaks about patient selection for peptide receptor radionuclide therapy (PRRT), with a focus on molecular imaging, and describes the challenges associated with this process.

  • When to refer patients to PRRT centre

    When to refer patients to PRRT centre Dr Mohid Khan describes the service model of NET care, information required for referral, patient preparation and selection, and more.
page 

Pages

 of  6
×

Ask Speakers

×

Medical Information Request